Create a free QxMD account to take advantage of the features offered by Read like saving your papers and creating collections.

Get Started

COMMENT

LETTER

Combined angiotensin inhibition in diabetic nephropathy

Myron Best, Jim de Wever, Yvo Smulders

New England Journal of Medicine 2014 February 20, 370 (8): 778

No abstract text is available yet for this article.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Combined angiotensin inhibition in diabetic nephropathy. Barbara Nikolaidou, Antonios Lazaridis, Michael Doumas New England Journal of Medicine 2014 February 20, 370 (8): 778-9

Combined angiotensin inhibition in diabetic nephropathy. Yuichiro Izumi, Katsumasa Kawahara, Hiroshi Nonoguchi New England Journal of Medicine 2014 February 20, 370 (8): 777-8

Combined angiotensin inhibition in diabetic nephropathy. Borja Quiroga, Gema Fernández Juárez, José Luño New England Journal of Medicine 2014 February 20, 370 (8): 777

Combined angiotensin inhibition in diabetic nephropathy. Linda F Fried, Nicholas Emanuele, Jane H Zhang New England Journal of Medicine 2014 February 20, 370 (8): 779

[Dual blockade of the renin-angiotensin system in diabetic patients is dangerous]. Johann Steurer Praxis 2014 February 26, 103 (5): 289-90

The end of dual therapy with renin-angiotensin-aldosterone system blockade? Dick de Zeeuw New England Journal of Medicine 2013 November 14, 369 (20): 1960-2

Potassium handling with dual renin-angiotensin system inhibition in diabetic nephropathy. Peter N Van Buren, Beverley Adams-Huet, Mark Nguyen, Christopher Molina, Robert D Toto Clinical Journal of the American Society of Nephrology: CJASN 2014, 9 (2): 295-301

Serum potassium in dual renin-angiotensin-aldosterone system blockade. Stephen L Seliger, Linda F Fried Clinical Journal of the American Society of Nephrology: CJASN 2014, 9 (2): 219-21

Design of combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor for treatment of diabetic nephropathy (VA NEPHRON-D). Linda F Fried, William Duckworth, Jane Hongyuan Zhang, Theresa O'Connor, Mary Brophy, Nicholas Emanuele, Grant D Huang, Peter A McCullough, Paul M Palevsky, Stephen Seliger, Stuart R Warren, Peter Peduzzi Clinical Journal of the American Society of Nephrology: CJASN 2009, 4 (2): 361-8

Combined angiotensin inhibition for the treatment of diabetic nephropathy. Linda F Fried, Nicholas Emanuele, Jane H Zhang, Mary Brophy, Todd A Conner, William Duckworth, David J Leehey, Peter A McCullough, Theresa O'Connor, Paul M Palevsky, Robert F Reilly, Stephen L Seliger, Stuart R Warren, Suzanne Watnick, Peter Peduzzi, Peter Guarino New England Journal of Medicine 2013 November 14, 369 (20): 1892-903

Make the most of Read.
Download the mobile app.

Want full text access to this paper?

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

Combined angiotensin inhibition in diabetic nephropathy

Discussion

Related Papers

Want full text access to this paper?

Save your favorite articles in one place with a free QxMD account.

Read

Search Tips